First Financial Corp’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.09K Hold
450
﹤0.01% 271
2026
Q1
$2.7K Hold
450
﹤0.01% 288
2025
Q4
$3.23K Hold
450
﹤0.01% 289
2025
Q3
$4.81K Hold
450
﹤0.01% 290
2025
Q2
$4.36K Hold
450
﹤0.01% 289
2025
Q1
$6.7K Hold
450
﹤0.01% 303
2024
Q4
$6.71K Hold
450
﹤0.01% 322
2024
Q3
$8.61K Hold
450
﹤0.01% 306
2024
Q2
$9.31K Sell
450
-3
-0.7% -$60 ﹤0.01% 309
2024
Q1
$8.51K Hold
453
﹤0.01% 349
2023
Q4
$6.53K Hold
453
﹤0.01% 330
2023
Q3
$7.86K Sell
453
-47
-9% -$980 ﹤0.01% 329
2023
Q2
$10.4K Hold
500
0.01% 288
2023
Q1
$11.8K Sell
500
-50
-9% -$1.34K 0.01% 287
2022
Q4
$15.4K Hold
550
0.01% 278
2022
Q3
$13K Sell
550
-50
-8% -$1.51K 0.01% 286
2022
Q2
$21K Sell
600
-20
-3% -$701 0.01% 260
2022
Q1
$21K Hold
620
0.01% 271
2021
Q4
$19K Sell
620
-89
-13% -$2.9K 0.01% 271
2021
Q3
$24K Sell
709
-332
-32% -$10.6K 0.02% 254
2021
Q2
$31K Buy
+1,041
New +$34.3K 0.02% 243

Other funds holding OGN

First Financial Corp's OGN Position: Q2 2026 in Review

First Financial Corp held its Organon & Co (OGN) position steady in Q2 2026 at 450 shares worth $6.09K. The position accounts for ﹤0.01% of the portfolio, ranked #271.

First Financial Corp first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $31K in Q2 2021. 107 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • First Financial Corp held 450 shares of Organon & Co worth $6.09K as of Q2 2026.
  • First Financial Corp left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of First Financial Corp's portfolio in Q2 2026, its #271 holding.
  • First Financial Corp first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • First Financial Corp's Organon & Co position peaked at $31K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on First Financial Corp's 13F filing for Q2 2026, filed 7 Jul 2026.